Condition: Chronic Pancreatitis · Chronic Pain · Sponsor: University of Pittsburgh
Abdominal pain in chronic pancreatitis (CP) affects up to 90% of patients during the course of their disease, and response to currently available therapies is suboptimal and unpredictable. The proposed clinical trial will evaluate the predictive capability of Pancreatic Quantitative Sensory Testing (P-QST) - a novel assessment of neurosensory phenotyping- for improvement in pain in patients with CP who are undergoing medically-indicated invasive treatment with endoscopic therapy or surgery.
This description comes directly from the study's public registry record.
Anna Evans Phillips, MD, MS · 412-647-2345 · evansac3@upmc.edu
Apsara Mishra · apm179@pitt.edu
Always discuss trial participation with your own doctor first.
| Indiana University Medical Center | Indianapolis, Indiana, United States | Recruiting |
| Johns Hopkins Medical Institutions | Baltimore, Maryland, United States | Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04996628